Ask AI
Bill116th CongressFiled Mar 5, 2020Armed Forces and National Security
H.R. 6092

Veteran's Prostate Cancer Treatment and Research Act

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house (Sep 22, 2020)

Veteran's Prostate Cancer Treatment and Research Act

This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer.

Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment.

The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually.

Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation.

Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.

What just happenedSep 23, 2020

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Who’s behind it

Rep. Dunn, Neal P. [R-FL-2](R-FL)Sponsor
3 cosponsors1 D2 R
Read on Congress.gov
3cosponsors2committees13actions10subjects
  1. Sep 23, 2020IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

    Veterans' Affairs Committee
  2. Sep 22, 2020FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Sep 22, 2020FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4684-4685)

  4. Sep 22, 2020Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

  5. Sep 22, 2020FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 6092.

  6. Sep 22, 2020FloorH30000

    Considered under suspension of the rules. (consideration: CR H4682-4685)

  7. Sep 22, 2020FloorH30300

    Mr. Takano moved to suspend the rules and pass the bill, as amended.

  8. Sep 17, 2020Committee

    Ordered to be Reported by Voice Vote.

    Veterans' Affairs Committee
  9. Sep 17, 2020Committee

    Committee Consideration and Mark-up Session Held.

    Veterans' Affairs Committee
  10. Sep 10, 2020Committee

    Committee Hearings Held.

    Veterans' Affairs Committee
  11. Mar 5, 2020IntroReferralH11100

    Referred to the House Committee on Veterans' Affairs.

    Veterans' Affairs Committee
  12. Mar 5, 2020IntroReferralIntro-H

    Introduced in House

  13. Mar 5, 2020IntroReferral1000

    Introduced in House

Passed HouseSep 22, 202053

Veteran's Prostate Cancer Treatment and Research Act

This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer.

Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment.

The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually.

Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation.

Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.

Introduced in HouseMar 5, 2020

Veteran's Prostate Cancer Treatment and Research Act

This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer.

Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment.

The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually.

Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation.

Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.

Veteran's Prostate Cancer Treatment and Research Act — Informed